INVO Fertility, Inc. (IVF) stock: key figures, P/E, revenue and dividend

Health Care · United States · ISIN US44984F8077

Price
2.60 USD
Market cap
76,103.95 USD
P/E (2025)
–
P/S (2025)
0.01
Dividend yield
0.00 %
Net margin
-340.92 %
Return on equity (ROE)
-322.85 %
Return on assets (ROA)
-115.35 %

INVO Fertility, Inc. financials

Fiscal year20242025
Revenue6.53 m USD6.84 m USD
Gross profit2.81 m USD6.81 m USD
Operating income-8.13 m USD-7.24 m USD
EBIT-8.06 m USD-22.17 m USD
Net income-9.10 m USD-23.32 m USD
Diluted EPS – continuing operations-30.19 USD-214.64 USD

Full history since 2010, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About INVO Fertility, Inc.

INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services and INVOcell Device segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. It also operates fertility clinics, including INVO Centers. The company was formerly known as NAYA Biosciences, Inc. and changed its name to INVO Fertility, Inc. in April 2025. INVO Fertility, Inc. was founded in 2007 and is based in Sarasota, Florida.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.